Evaluation of tumour infiltrating immune cells into the orthotopic and metastatic tumour microenvironment using bioluminescent syngeneic cell line models in immune competent mice following treatment with checkpoint inhibitors

被引：0
|
作者：
Andrew, M. [1 ]
Nektaria, P. [1 ]
Simon, J. [1 ]
Jane, W. [2 ]
Jason, K. [2 ]
Vicky, L. [2 ]
Kelly, J. [2 ]
Russell, G. [3 ]
Neil, W. [4 ]
Kumari, R. [5 ]
机构：
[1] Crown Biosci UK Ltd, Sci Operat, Loughborough, Leics, England
[2] Crown Biosci UK Ltd, Vitro Operat, Loughborough, Leics, England
[3] KWS Biotest, Analyt Serv, Bristol, Avon, England
[4] KWS Biotest, Bristol, Avon, England
[5] Crown Biosci UK Ltd, Loughborough, Leics, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)32930-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
337
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 23 条
  • [1] Evaluation of checkpoint inhibitors on tumour infiltrating immune cells in the orthotopic and metastatic tumour microenvironment using bioluminescent syngeneic cell line models
    McKenzie, Andrew
    Papadopoulou, Nektaria
    Jiang, Simon
    Wrigley, Jane
    Malhi, Sumanjeet
    King, Jason
    Jones, Kelly
    Williams, Neil
    Kumari, Rajendra
    CANCER RESEARCH, 2017, 77
  • [2] Recapitulating the orthotopic tumour microenvironment using bioluminescent syngeneic models in immune competent mice for checkpoint inhibitor interrogation
    Papadopoulou, N.
    Davies, J.
    Wainwright, L.
    Wrigley, J.
    Jiang, S.
    King, J.
    Yin, Y.
    Kumari, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E109 - E110
  • [3] Recapitulating the orthotopic tumor microenvironment using bioluminescent syngeneic models in immune competent mice for checkpoint inhibitor interrogation
    Obeng, Joyce Afrakoma
    Jetha, Maya
    Wrigley, Jane
    Jiang, Simon
    King, Jason
    Kumari, Rajendra
    Yin, Yinfei
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Check point inhibitor modulation of tumor microenvironment at orthotopic and metastatic sites using bioluminescent syngeneic cell line models in immune competent mice
    McKenzie, Andrew
    Papadopoulou, Nektaria
    Jiang, Simon
    Wrigley, Jane
    Jones, Kelly
    Garland, Russell
    Williams, Neil
    Kumari, Rajendra
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [5] Tumour infiltrating lymphocytes characterization in advanced nonsmall cell lung cancer with first-line immune checkpoint inhibitors treatment
    Ruivo, L.
    Pinho Fialho, M.
    Baptista, D.
    Filipe, J.
    VIRCHOWS ARCHIV, 2024, 485 : S450 - S450
  • [6] TARGETING SIALIC ACID ON STROMAL CELLS REVERSES T CELL SUPPRESSION IN THE COLORECTAL TUMOUR MICROENVIRONMENT A NEW TUMOUR STROMAL CELL IMMUNE CHECKPOINT
    Ryan, Aideen
    Treacy, Oliver
    Lynch, Kevin
    De Veirman, Kim
    Vanderkerken, Karin
    Egan, Laurence
    Ritter, Thomas
    Hogan, Aisling
    Redmond, Keara
    Hynes, Sean
    Kerr, Emma
    O'Dwyer, Michael
    Dunne, Philip
    Leonard, Niamh
    Egan, Hannah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1503 - A1504
  • [7] Immune checkpoint inhibitors in the first-line treatment of metastatic small-cell lung cancer
    Knetki-Wroblewska, Magdalena
    Kowalski, Dariusz M.
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (02): : 104 - 114
  • [8] Immune competent syngeneic models demonstrate additive effects of combination strategies using checkpoint immunotherapy and inducers of immunogenic cell death (ICD)
    Mckenzie, Andrew
    Kumari, Rajendra
    Shi, Qian
    Papadopoulou, Nektaria
    Yin, Yinfei
    Jiang, Simon
    Wrigley, Jane
    King, Jason
    Williams, Neil
    Garland, Russell
    CANCER RESEARCH, 2016, 76
  • [9] Tumour Burden as a Predictive Tool of Response to Immune Checkpoint Inhibitors (ICI) in Patients with Metastatic Non-Small-Cell Lung Cancer
    Icht, O.
    Domachevsky, L.
    Groshar, D.
    Dudnik, E.
    Rotem, O.
    Peled, N.
    Reinhorn, D.
    Jacobi, O.
    Shochat, T.
    Bernstine, H.
    Zer, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S531 - S532
  • [10] Characterising changes in the immune cell population of the tumour microenvironment following treatment with external beam ionising radiation and a TLR7 agonist
    Pollard, C.
    Adlard, A.
    Honeychurch, J.
    Illidge, T.
    Dovedi, S.
    VIRCHOWS ARCHIV, 2014, 465 : S284 - S285
123